Bioten Co., Ltd. (XKON:289170)
South Korea · Delayed Price · Currency is KRW 2,500.00
-50.00 (-1.96%)
At close: Nov 13, 2026
Bioten Market Cap
Bioten has a market cap or net worth of 8.94 billion as of November 13, 2026. It is the 43,340th most valuable company in the world and the 2,648th biggest in South Korea. Its market cap has decreased by 16.53% in one year.
Market Cap
8.94B
Enterprise Value
n/a
Revenue
10.71B
Global Rank
Country Rank
#2,648 South Korea
PE Ratio
7.60
ChartMarket Cap Chart
Since October 13, 2023, Bioten's market cap has decreased from 23.56B to 8.94B, a decrease of -62.05%. That is a compound annual growth rate of -26.93%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 8.94B | -29.78% |
| Dec 30, 2025 | 12.73B | -29.50% |
| Dec 30, 2024 | 18.06B | 65.39% |
| Dec 28, 2023 | 10.92B | -53.65% |
| Oct 13, 2023 | 23.56B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pharmsville | 25.89B |
| Baskhanbio Pharma | 24.49B |
| Seoul Pharma | 20.40B |
| Daesung Microbiological Labs. | 20.14B |
| Union Korea Pharm | 19.70B |
| BIFIDO | 19.30B |
| WooGene B&G | 19.06B |
| Hurum | 18.70B |